CTRI/2017/06/008931招募中2 期
An open clinical trial of Siddha drugs â??Akkini chooranamâ?? (internal) and â??Veera mezhuguâ?? (external) in the treatment of â??Kuthikaal vaathamâ?? (Plantar fasciitis)
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Pain and tenderness in the sole of the foot while on walking and standing
排除标准
- •1.H/o Cardiac diseases
- •2.H/o Diabetes mellitus
- •3.H/o Rheumatoid arthritis
- •4.H/o Chronic kidney disease
- •5.Pregnancy and lactation
- •6.Septic arthritis
- •7.Gonococcal arthritis
- •8.Psoriatic arthritis
- •9.Patient with any other serious systemic illness.
研究者
相似试验
招募中
3 期
A clinical research of siddha medicine in the management of Psoriasis (Kalanjagapadai)CTRI/2017/06/008923ational Institute of Siddha40
已完成
3 期
ASSESSMENT OF THERAPEUTIC EFFICACY OF SIDDHA FORMULARY DRUG SWASAKASA NEI IN THE MANAGEMENT OF SWASAKASAM (BRONCHIAL ASTHMA)CTRI/2021/07/035137ational Institute of Siddha30
尚未招募
不适用
Peenisam (Chronic rhinosinusitis) management with siddha external formulations pugai and nasiyamCTRI/2019/09/021107Dr L Nilopher
尚未招募
1 期
Clinical study of Venneer Noi (Dhat Syndrome) with Siddha Medical TherapyCTRI/2017/01/007668AYOTHIDOSS PANDITHAR HOSPITA40
进行中（未招募）
不适用
Eine offene, prospektive Studie zur Untersuchung der Pharmakokinetikund Sicherheit (Teil A) des Immunglobulins vom Menschen zurintravenösen Infusion (IVIG) BT090 sowie der Verträglichkeit undSicherheit von steigenden Infusionsgeschwindigkeiten (Teil B) beiPatienten mit primären Immundefekten (PID)Primary immunodeficiency disease (PID)MedDRA version: 13.1Level: LLTClassification code 10010509Term: Congenital hypogammaglobulinemiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2010-019249-25-HUBiotest AG30